JP2010519311A5 - - Google Patents

Download PDF

Info

Publication number
JP2010519311A5
JP2010519311A5 JP2009550992A JP2009550992A JP2010519311A5 JP 2010519311 A5 JP2010519311 A5 JP 2010519311A5 JP 2009550992 A JP2009550992 A JP 2009550992A JP 2009550992 A JP2009550992 A JP 2009550992A JP 2010519311 A5 JP2010519311 A5 JP 2010519311A5
Authority
JP
Japan
Prior art keywords
acid
epimer
dtran
oil
ddan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009550992A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010519311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/054456 external-priority patent/WO2008103753A2/en
Publication of JP2010519311A publication Critical patent/JP2010519311A/ja
Publication of JP2010519311A5 publication Critical patent/JP2010519311A5/ja
Pending legal-status Critical Current

Links

JP2009550992A 2007-02-20 2008-02-20 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法 Pending JP2010519311A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89070107P 2007-02-20 2007-02-20
PCT/US2008/054456 WO2008103753A2 (en) 2007-02-20 2008-02-20 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same

Publications (2)

Publication Number Publication Date
JP2010519311A JP2010519311A (ja) 2010-06-03
JP2010519311A5 true JP2010519311A5 (https=) 2011-04-07

Family

ID=39710725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009550992A Pending JP2010519311A (ja) 2007-02-20 2008-02-20 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法

Country Status (5)

Country Link
US (1) US20110190389A1 (https=)
EP (1) EP2120920A4 (https=)
JP (1) JP2010519311A (https=)
CN (1) CN101663031A (https=)
WO (1) WO2008103753A2 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2679224A1 (en) 2007-08-01 2014-01-01 University of Pittsburgh of the Commonwealth System of Higher Education Nitro oleic acid modulation of type II diabetes
CN102083787A (zh) 2008-05-01 2011-06-01 康普雷克萨公司 乙烯基取代的脂肪酸
US20140024713A1 (en) 2008-06-19 2014-01-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
WO2009155439A2 (en) 2008-06-19 2009-12-23 University Of Utah Research Foundation Use of nitrated lipids for treatment of side effects of toxic medical therapies
ES2792676T3 (es) * 2008-09-16 2020-11-11 Brigham & Womens Hospital Inc Compuestos del ácido 14-hidroxi-docosahexaenoico
EP2415748A4 (en) 2009-02-20 2013-08-07 Univ Tokyo NEW INFLAMMATORY COMPOUNDS
FR2942964B1 (fr) * 2009-03-16 2012-08-17 Arkopharma Laboratoires Stimulateur metabolique des ppaps a base d'esters d'acides gras libres insatures, composition huileuse et complement alimentaire les contenant
EP2283839A1 (en) * 2009-06-30 2011-02-16 Institut National des Sciences Appliquées de Lyon Polyunsaturated hydroxylated molecule having an eze geometry and its use in therapy
EP2459189A4 (en) * 2009-07-31 2013-01-16 Univ Pittsburgh FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
WO2011041639A2 (en) 2009-10-02 2011-04-07 Miller Raymond A Heteroatom containing substituted fatty acids
AU2012285806B2 (en) * 2011-07-21 2017-09-14 Dsm Ip Assets B.V. Fatty acid compositions
EP2744491B1 (en) 2011-08-19 2020-07-29 The University of Utah Research Foundation Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
CN103957888B (zh) * 2011-09-29 2017-11-21 PLx 制药公司 用于将药物沿胃肠道靶向释放的pH依赖性载体、其组合物及其制备和应用
UA114615C2 (uk) 2012-01-06 2017-07-10 Омтера Фармасьютікалз, Інк. Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти
EP2809317A4 (en) * 2012-02-03 2015-07-22 Univ Pittsburgh FATTY ACIDS AS ANTI-INFLAMMATORY ACTIVE SUBSTANCES
US9340483B2 (en) * 2012-02-15 2016-05-17 Anida Pharma Inc. Methods of treating amyotrophic lateral sclerosis
HK1206248A1 (en) 2012-05-07 2016-01-08 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids
DK2858496T3 (da) 2012-05-10 2023-07-24 Solutex Na Llc Olier med anti-inflammatorisk aktivitet, som indeholder naturlige specialiserede pro-afhjælpningsmediatorer og deres forløbere
PL2887923T3 (pl) 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
EP3892608B1 (en) * 2013-05-30 2025-07-23 The Brigham and Women's Hospital, Inc. Novel n-3 immunoresolvents: structures and actions
DK3097910T3 (da) * 2014-01-24 2020-07-27 Univ Kyoto Antiinflamatorisk middel indeholdende sjælden fedtsyre
JP6315536B2 (ja) * 2014-01-29 2018-04-25 岩手県 Ｐｐａｒ活性化剤
US11135228B2 (en) * 2014-10-08 2021-10-05 The Brigham And Women's Hospital, Inc. Cysteinyl-proresolving mediators that promote resolution of infection and organ protection
HRP20240082T1 (hr) 2015-07-07 2024-03-29 H. Lundbeck A/S Inhibitor pde9 s okosnicom imidazopirazinona za liječenje perifernih bolesti
US20180208536A1 (en) * 2015-07-20 2018-07-26 The Brigham And Women's Hospital, Inc. Elucidation of Novel 13-Series Resolvins that Increase with Atorvastatin and Clear Infections
KR20170025977A (ko) * 2015-08-31 2017-03-08 재단법인차세대융합기술연구원 옥시리스 마리나로부터 분리된 신규 화합물
US10653703B2 (en) 2015-09-03 2020-05-19 Solutex Na Llc Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same
IL258476B2 (en) 2015-10-02 2023-04-01 Complexa Inc Prevention, treatment and reversal of disease using therapeutically effective amounts of activated fatty acids
EP3373976B1 (en) 2015-11-10 2024-01-03 Sun Pharmaceutical Industries Limited Topical formulations and uses thereof
WO2017208173A1 (en) * 2016-06-01 2017-12-07 National Research Council Of Canada Winter aconite fatty acid elongase and uses thereof in the production of fatty acids
EP3792351A4 (en) 2018-04-16 2022-01-19 Korea Research Institute of Bioscience and Biotechnology Method for producing multi-hydroxy derivatives of polyunsaturated fatty acids
FI3801526T3 (fi) 2018-05-25 2024-03-20 Cardurion Pharmaceuticals Inc 6-[(3s,4s)-4-metyyli-1-(pyrimidin-2-yylimetyyli)pyrrolidin-3-yyli]-3-tetrahydropyran-4-yyli-7h-imidatso[1,5-a]pyratsin-8-onin monohydraattimuotoja ja kiteisiä muotoja
EP3843737A4 (en) 2018-08-31 2022-06-01 Imara Inc. PDE9 INHIBITORS FOR THE TREATMENT OF SICKLE CELL DISEASE
CN109161576B (zh) * 2018-09-26 2020-08-07 武汉中科光谷绿色生物技术有限公司 促进枯草芽孢杆菌发酵生产n-乙酰神经氨酸的方法
KR102673270B1 (ko) * 2018-10-15 2024-06-07 (주)아모레퍼시픽 피부장벽 강화용 조성물
KR102704402B1 (ko) 2018-10-24 2024-09-06 (주)아모레퍼시픽 피부장벽 강화용 조성물
CA3155544A1 (en) * 2019-10-25 2021-04-29 Stuart Littler Enriched polyunsaturated fatty acid compositions
JP7220940B2 (ja) * 2020-02-18 2023-02-13 国立大学法人北海道大学 レゾルビンｅ２の安定等価体
KR20220159751A (ko) 2021-05-26 2022-12-05 (주)아모레퍼시픽 미백용 조성물 및 이를 이용한 피부 미백방법
US20250009697A1 (en) * 2021-11-16 2025-01-09 House Foods Group Inc. Composition for increasing amount of food ingested and/or improving anorexia, and composition for activating transient receptor potential ankyrin 1
CN114354785B (zh) * 2021-12-22 2023-06-27 中国农业科学院油料作物研究所 一种基于保留指数结合化学衍生化质谱特征二级碎片的氧脂素综合定性方法
WO2024108603A1 (zh) * 2022-11-25 2024-05-30 中国科学院深圳先进技术研究院 基于粪便代谢物的神经退行性疾病标志物及其应用
FR3148365A1 (fr) * 2023-05-04 2024-11-08 Pierre Fabre Dermo-Cosmetique Oxylipines dans le traitement de la séborrhée et/ou de l’acné
CN121027545B (zh) * 2025-10-31 2026-02-03 华中科技大学同济医学院附属协和医院 甲状腺相关眼病的负离子代谢标志物、产品及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin
US5102670A (en) * 1990-09-14 1992-04-07 Abraham Nader G Method for treating eye disorders by reducing 12(r)-hydroxyeicosatetraenoic acid and 12(r)-dihydroxyeicosatrienoic acid levels
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US6887901B1 (en) * 1993-06-15 2005-05-03 Brigham & Women's Hospital, Inc. Lipoxin compounds and their use in treating cell proliferative disorders
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
US5955496A (en) * 1996-08-13 1999-09-21 The Regents Of The University Of California Dihydroxy-oxy-eicosadienoates
ATE236627T1 (de) * 1996-10-11 2003-04-15 Scarista Ltd Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
US6174695B1 (en) * 1997-08-12 2001-01-16 The Regents Of The University Of California Epoxide hydrolase inhibitor methods
DE19757414A1 (de) * 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
KR100423013B1 (ko) * 1999-03-04 2004-03-12 산토리 가부시키가이샤 도코사펜타엔산 함유물질의 이용
CA2378968A1 (en) * 1999-07-07 2001-01-18 Kyowa Hakko Kogyo Co., Ltd. Process for producing hydroxylated fatty acid and o-lactones
JP4932116B2 (ja) * 2000-02-16 2012-05-16 ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド アスピリン誘発脂質メディエータ
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US7154022B2 (en) * 2000-10-06 2006-12-26 Board Of Trustees Operating Michigan State University Divinyl ether synthase gene, and protein and uses thereof
EP1392623A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
US7527935B2 (en) * 2002-03-19 2009-05-05 Mitsubishi Tanabe Pharma Corporation G-protein coupled receptor having eicosanoid as ligand and gene thereof
US7582785B2 (en) * 2002-04-01 2009-09-01 University Of Southern California Trihydroxy polyunsaturated eicosanoid derivatives
WO2003084305A2 (en) * 2002-04-01 2003-10-16 University Of Southern California Trihydroxy polyunsaturated eicosanoids
FR2843124B1 (fr) * 2002-08-02 2004-10-15 Goemar Lab Sa Procede de preparation d'acides gras polyinsatures libres et de leurs metabolites d'oxydation
DE60330154D1 (de) * 2002-08-12 2009-12-31 Brigham & Womens Hospital Resolvine: biotemplate zur durchführung therapeutischer anwendungen
US20040166130A1 (en) * 2002-12-23 2004-08-26 L'oreal Lanolin-free cosmetic composition comprising a hydroxylated fatty acid aromatic ester
US7893106B2 (en) * 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
WO2006055965A2 (en) * 2004-11-19 2006-05-26 Martek Biosciences Corporation Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same

Similar Documents

Publication Publication Date Title
JP2010519311A5 (https=)
JP2008520739A5 (https=)
US7884131B2 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
US7893106B2 (en) Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
JP2010519311A (ja) 長鎖多価不飽和脂肪酸由来のオキシリピンならびにその作製およびその使用方法
DE60124256T3 (de) Aspirin-ausgelöste lipidmediatoren
JP2010532418A5 (https=)
JP7242769B2 (ja) 遊離多価不飽和脂肪酸含有組成物及びその製造方法
JP2009519032A (ja) ドコサヘキサエン酸（ｄｈａ）産生スラウストキトリウム菌株‐ｓｃ１
EP1983977A2 (en) Oxylipins from stearidonic acid and gamma-linolenic acid and methods of making and using the same
AU743992B2 (en) Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same
JPWO2006022356A1 (ja) ジアシルグリセロールの含量を任意に含んだ微生物油脂の製造法並びに該油脂
JPWO2019208803A1 (ja) 微生物油及び微生物油の製造方法
JP3931219B2 (ja) 高度不飽和脂肪酸含有油脂の製造方法
JP2001245688A (ja) ５，１１，１４−エイコサトリエン酸及び／又は５，１１，１４，１７−エイコサテトラエン酸を含有する脂質及びその製造方法
JP2010094111A (ja) 高度不飽和脂肪酸の製造方法
KR100900030B1 (ko) 고순도 불포화 지방산의 제조방법
JP3544247B2 (ja) 血小板凝集能抑制用薬剤組成物
AU2011253846A1 (en) Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
JP2007089522A (ja) 特定の高度不飽和脂肪酸が濃縮された脂肪酸組成物の製造方法
JP2006061021A (ja) １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
JPH0319694A (ja) ドコサヘキサエン酸グリセリドの濃縮法
US20110027841A1 (en) Method for preparation of oxylipins
NO20220910A1 (en) Cetoleic acid composition
JP2005087194A (ja) 微生物を用いた共役高度不飽和脂肪酸含有培養物および共役高度不飽和脂肪酸含有油脂の製造方法